Sorafenib

Name: Sorafenib - MedsBase.com
SKU: Soranib
Availability: OutOfStock

✅ Inhibits cancer cell growth
✅ Treats kidney, liver cancers
✅ Manages thyroid carcinoma
✅ Slows tumor progression
✅ Reduces cancer symptoms

SKU: Soranib Categories: Anti Cancer Medication, Category Overview, Chronic Conditions

Soranib Tablet is classified as a tyrosine kinase inhibitor medication prescribed for treating liver cancer, kidney cancer, and thyroid cancer.

For optimal effectiveness, take Soranib Tablet on an empty stomach at the same time each day. Your physician will determine the appropriate dosage and frequency based on your specific condition, which may be adjusted periodically. Strictly follow your doctor’s instructions, as improper use or overdose can lead to severe adverse effects. While benefits may take weeks or months to become apparent, continue treatment unless directed otherwise by your healthcare provider.

Common side effects include tiredness, nausea, decreased appetite, hair thinning, and diarrhea. This medication may elevate blood pressure, requiring regular monitoring. Immediately report any severe skin reactions, rashes, or pain/swelling in extremities to your doctor.

Prior to treatment, disclose any history of cardiovascular conditions, hepatic/renal impairment, or hypertension. Inform your medical team about all concurrent medications due to potential interactions. Soranib is contraindicated during pregnancy and lactation. Both male and female patients must use reliable contraception throughout therapy to prevent pregnancy.

THERAPEUTIC APPLICATIONS OF SORANIB TABLET

Hepatocellular carcinoma (Liver cancer)
Renal cell carcinoma (Kidney cancer)
Differentiated thyroid carcinoma

CLINICAL BENEFITS OF SORANIB TABLET

In Hepatic Malignancies

Primary liver cancer originates in hepatocytes and often remains asymptomatic during early stages. Advanced disease may manifest through cachexia, abdominal discomfort, emesis, and jaundice. Soranib Tablet exerts its therapeutic effect by selectively targeting and destroying malignant cells while inhibiting tumor progression and metastasis. Adherence to prescribed treatment protocols is essential. Patients should abstain from alcohol consumption and tobacco use, as these substances may exacerbate disease progression and compromise therapeutic outcomes.

ADVERSE EFFECTS OF SORANIB TABLET

Most adverse reactions are transient and resolve as your system adapts to the medication. Persistent or concerning symptoms warrant medical consultation.

Frequently observed reactions

Asthenia (fatigue)
Gastrointestinal disturbances
Anorexia
Loose stools
Abdominal discomfort
Alopecia
Decreased body weight
Cutaneous eruptions
Palmar-plantar erythrodysesthesia

ADMINISTRATION GUIDELINES

Ingest the tablet whole with water, without chewing or crushing, exactly as prescribed. Maintain consistent fasting conditions (1 hour before or 2 hours after meals) for each dose.

MECHANISM OF ACTION

As a multi-kinase inhibitor, Soranib Tablet exerts its antineoplastic effects by selectively inhibiting tyrosine kinase enzymes involved in tumor proliferation and angiogenesis, thereby impeding cancer progression.

Important Notice:

This content is provided for educational purposes only after thorough medical review. The information presented should not supersede professional medical advice, diagnosis, or treatment. This overview may not encompass all potential adverse reactions, contraindications, or medication interactions. Always consult your healthcare provider regarding any medical condition or therapeutic regimen. This resource is designed to complement, not replace, the crucial relationship between patients and their physicians.

Strength	200 mg
Quantity	120 Tablet/s, 240 Tablet/s
Pharma Form	Tablet/s
Manufacturer	Cipla Inc
Treatment	Liver cancer, Kidney cancer, Thyroid cancer
Generic Brand	Sunitinib